Applied Therapeutics Ownership | Who Owns Applied Therapeutics?

Overview Forecast RevenueFinancials Chart

Applied Therapeutics Ownership Summary

Applied Therapeutics is owned by 60.62% institutional investors, 5.61% insiders, and 33.78% retail investors. T. rowe price investment management is the largest institutional shareholder, holding 14.75% of APLT shares. T. Rowe Price Small-Cap Value is the top mutual fund, with 8.27% of its assets in Applied Therapeutics shares.

APLT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Applied Therapeutics	60.62%	5.61%	33.78%
Sector	Healthcare Stocks	492.67%	11.09%	-403.76%
Industry	Biotech Stocks	295.31%	11.22%	-206.53%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
T. rowe price investment management	21.40M	14.75%	$12.84M
Vestal point capital, lp	14.25M	9.82%	$8.62M
Propel bio management	11.29M	7.78%	$6.83M
Knoll capital management	7.80M	5.38%	$4.71M
Blackrock	6.57M	5.24%	$30.68M
Susquehanna group, llp	556.00K	3.85%	$476.05K
Vanguard group	5.10M	3.52%	$3.09M
Simplify asset management	4.49M	3.09%	$2.71M
Blackrock funding, inc. /de	3.84M	2.65%	$2.33M
Pnc financial services group	2.90M	2.00%	$1.76M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Propel bio management	11.29M	6.83%	$6.83M
Stempoint capital lp	2.21M	3.03%	$10.33M
Knoll capital management	7.80M	2.52%	$4.71M
Vestal point capital, lp	14.25M	0.39%	$8.62M
Artal group	1.01M	0.12%	$4.71M
Birchview capital, lp	225.00K	0.10%	$136.10K
Rock springs capital management lp	2.08M	0.07%	$1.26M
Simplify asset management	4.49M	0.05%	$2.71M
Scientech research	105.11K	0.02%	$63.58K
T. rowe price investment management	21.40M	0.01%	$12.84M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	6.57M	0.00%	5.58M
Pnc financial services group	2.90M	0.00%	2.90M
Vestal point capital, lp	14.25M	0.39%	2.75M
T. rowe price investment management	21.40M	0.01%	2.72M
Ubs group	1.91M	0.00%	1.07M

Top Sellers

Holder	Shares	% Assets	Change
Vr adviser	-	-	-5.57M
Alyeska investment group	-	-	-3.11M
Tang capital management	-	-	-2.43M
Frazier life sciences management	-	-	-2.29M
Siren	-	-	-1.63M

New Positions

Holder	Shares	% Assets	Change	Value
Pnc financial services group	2.90M	0.00%	2.90M	$1.76M
Hudson bay capital management lp	673.76K	0.00%	673.76K	$407.56K
Rockefeller capital management	391.90K	0.00%	391.90K	$237.06K
Norges bank	243.20K	-	243.20K	$208.23K
Ubs asset management americas	119.03K	-	119.03K	$101.89K

Sold Out

Holder	Change
Ifp advisors	-1.00
National bank of canada /fi/	-4.00
Advisor group	-20.00
Headlands	-23.00
Geowealth management	-27.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	76	-19.15%	87,954,198	-17.06%	60	0.97%	29	-29.27%	30	-9.09%
Mar 31, 2025	7	-94.62%	37,179,368	-67.70%	27	0.00%	2	-97.53%	2	-92.31%
Dec 31, 2024	127	-11.19%	109,297,179	-3.04%	757	0.12%	79	-8.14%	26	-18.75%
Sep 30, 2024	143	41.58%	112,721,880	9.20%	780	11.51%	85	37.10%	33	37.50%
Jun 30, 2024	101	1.00%	103,226,978	9.86%	82	1.47%	62	-7.46%	24	50.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
T. Rowe Price Small-Cap Value	11.91M	8.27%	436.17K
T. Rowe Price U.S. SC Value Eq Tr-D	6.65M	4.70%	3.00M
Simplify Propel Opportunities ETF	4.49M	3.16%	-
Vanguard US Total Market Shares ETF	3.15M	2.71%	-
T. Rowe Price U.S. SC Value Eq Tr-Z	3.65M	2.66%	1.76M
Vanguard Total Stock Mkt Idx Inv	3.04M	2.14%	-66.40K
SPDR® S&P Biotech ETF	1.74M	1.49%	24.74K
Janus Henderson Global Life Sciences D	1.62M	1.39%	1.30M
Janus Henderson Glb Life Scn I2 USD	1.29M	1.11%	1.29M
Franklin Biotechnology Discv A(acc)USD	1.26M	0.88%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 04, 2025	Perfetti Riccardo	Chief Medical Officer	Sell	$4.56K
Mar 04, 2025	Funtleyder Leslie D.	See Remarks	Sell	$6.38K
Mar 04, 2025	Chinoporos Constantine	See Remarks	Sell	$196.68
Feb 06, 2025	Funtleyder Leslie D.	See Remarks	Sell	$14.00K
Feb 06, 2025	Perfetti Riccardo	Chief Medical Officer	Sell	$52.51K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	6
2024 Q4	-	-

APLT Ownership FAQ

Who Owns Applied Therapeutics?

Applied Therapeutics shareholders are primarily institutional investors at 60.62%, followed by 5.61% insiders and 33.77% retail investors. The average institutional ownership in Applied Therapeutics's industry, Biotech Stocks , is 295.31%, which Applied Therapeutics falls below.

Who owns the most shares of Applied Therapeutics?

Applied Therapeutics’s largest shareholders are T. rowe price investment management (21.4M shares, 14.75%), Vestal point capital, lp (14.25M shares, 9.82%), and Propel bio management (11.29M shares, 7.78%). Together, they hold 32.35% of Applied Therapeutics’s total shares outstanding.

Does Blackrock own Applied Therapeutics?

Yes, BlackRock owns 5.24% of Applied Therapeutics, totaling 6.57M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 30.68M$. In the last quarter, BlackRock increased its holdings by 5.58M shares, a 564.10% change.

Who is Applied Therapeutics’s biggest shareholder by percentage of total assets invested?

Propel bio management is Applied Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.83% of its assets in 11.29M Applied Therapeutics shares, valued at 6.83M$.

Who is the top mutual fund holder of Applied Therapeutics shares?

T. Rowe Price Small-Cap Value is the top mutual fund holder of Applied Therapeutics shares, with 8.27% of its total shares outstanding invested in 11.91M Applied Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools